Latest biopharmaceutical Stories
FREMONT, Calif., Dec. 1, 2014 /PRNewswire/ -- Ardelyx, Inc.
DALLAS and NEW YORK, Nov. 24, 2014 /PRNewswire/ -- PlasmaTech Biopharmaceuticals, Inc. announced today that FINRA has approved a change of Company's stock ticker symbol.
BOULDER, Colo., Nov. 19, 2014 /PRNewswire/ -- N30 Pharmaceuticals, Inc.
-- Data Published Online in the Journal of the American Society of Nephrology -- FREMONT, Calif., Nov. 17, 2014 /PRNewswire/ -- Ardelyx, Inc.
- Treatment with RG-012 Protects Kidney Function and Demonstrates Additive Therapeutic Effect with Emerging Standard of Care in Preclinical Model of Alport Syndrome - LA JOLLA, Calif.,
U.S. Patent No. 8,871,493 "Transformation system in the field of filamentous fungal hosts" JUPITER, Fla., Nov. 12, 2014 /PRNewswire/ -- Dyadic International, Inc.
All amounts are in US dollars QUEBEC CITY, Nov. 4, 2014 /PRNewswire/ - Aeterna Zentaris Inc.
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.